By Dr Melvin Teck Meng Chin

Conference Papers

Chong YS; Redmayne G; Chin M, 2024, 'Compassionate access drug use for oncology treatment: Single institution retrospective audit 2017-2024', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 147 - 148

Taggart J; Chin M; Liauw W; Spooner C; Barr M; Li XS; Harris M, 2022, 'Enhancing shared care between health services and primary health care using an interactive e-care plan in South Eastern Sydney Local Health District', in AUSTRALIAN JOURNAL OF PRIMARY HEALTH, CSIRO PUBLISHING, pp. LIX - LIX

Abdelmogod A; Robinson L; Coleman L; Chah K; Chin M; O'Neill S, 2020, 'Retrospective analysis of chemotherapy-induced febrile neutropenia; Local experience towards risk-based management', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 142 - 142

Chin TTC; Botes LLB; Chin MMC, 2017, 'Compassionate Supply of Oncology Drugs Within the South Eastern Sydney Local Health District (SESLHD) in 2011-2015', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 188 - 188

Au L; Grant M; Haydon A; Oliva K; Wilkins S; Segelov E; Antill Y; Peter C; Ranchod P; Polglase A; Chin M; Chip F; Skinner S; Roger W; McMurrick P; Shapiro J, 2016, 'Use of chemotherapy and mismatch repair deficiency testing in resected stage II colon cancer', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS

Segelov E, 2015, 'TOPS - a randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue', Chicago, presented at 2015 ASCO Annual Meeting, Chicago, 29 May 2015 - 02 June 2015

Feeney K; Chin M; Ng S; Matos M; Mak G; McKendrick J, 2014, 'AFLIBERCEPT IN METASTATIC COLORECTAL CANCER (MCRC): DATA FROM CLINICAL TRIALS, LESSONS FROM CLINICAL PRACTICE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 192 - 192

Sandler C; Webber K; Friedlander M; Lewis C; Chin M; Venkateswaran R; Segelov E; Bastick P; Lynch J; Thomas D; Liauw W; Boyle F; Goldstein D; Lloyd A, 2013, 'BARRIERS TO RECRUITMENT FOR A POST-CANCER FATIGUE INTERVENTION STUDY - THE TOPS TRIAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lemech C; Fontela A; Arkenau H; Chin M; Li S; Liauw WS; Thomas D; De Souza P, 2012, 'Phase I study of everolimus in combination with fluvastatin and zoledronic acid in patients with solid tumours', in Journal of clinical oncology - official journal of the American Society of Clinical Oncology, American Society of Clinical Oncology, New York, pp. e13585 - e13585, presented at ASCO Annual Meeting, Chicago, USA, 01 June 2012 - 05 June 2012, http://meeting.ascopubs.org/gca?gca=ascomtg%3B30%2F15_suppl%2Fe13585&allch=&submit=Go#abstr-1

Herder GJ; Agulnik J; Amadori D; Chin M; Chouaid C; Ek L; Lester J; Ziske C; Eriksson J; Finnern H; Vansteenkiste J, 2011, 'Describing treatment, treatment outcomes, resource use and quality of life of advanced NSCLC patients – the Lung Cancer Economics and Outcomes Research (LUCEOR) studies.', in Journal of Thoracic Oncology, Lippincott Williams & Wilkins, USA, pp. 1404 - 1405, presented at Proceedings of the 14th World Conference on Lung Cancer, Amsterdam, http://dx.doi.org/10.1097/01.JTO.0000399290.73317.eb

Herder GJM; Agulnik J; Amadori D; Chin M; Chouaid C; Ek L; Lester J; Ziske C; Eriksson J; Finnern H; Vansteenkiste J, 2011, 'DESCRIBING TREATMENT, TREATMENT OUTCOMES, RESOURCE USE AND QUALITY OF LIFE OF ADVANCED NSCLC PATIENTS - THE LUNG CANCER ECONOMICS AND OUTCOMES RESEARCH (LUCEOR) STUDIES', in JOURNAL OF THORACIC ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, pp. S1404 - S1405

Pearson S; Chin M; Ward RL, 2009, 'The Financially Tolerable Dose: A New Concept in Cancer Trial Design', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S173 - S174

Back to profile page